<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01405313</url>
  </required_header>
  <id_info>
    <org_study_id>MA231210</org_study_id>
    <nct_id>NCT01405313</nct_id>
  </id_info>
  <brief_title>Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV</brief_title>
  <official_title>Comparison of Modified Adaptive Servoventilation Therapy With Conventional Adaptive Servoventilation Therapy in Patients With Periodic Breathing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine if modified adaptive servoventilation (ASV) is as effective as the
      conventional ASV in treating periodic breathing. The study will determine if the modified ASV
      reacts appropriately to reduce apneas and hypopneas and provides suitable levels of positive
      airway pressure compared to conventional ASV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adaptive servoventilation (ASV) is a type of non-invasive ventilation which ameliorates
      central sleep and/or mixed apnea and periodic breathing. Previous studies in the field have
      shown that treatment of periodic breathing with ASV improves sleep quality and quality of
      life. In reducing central apneas, ASV reduces overall arousal index, and increases overall
      slow wave sleep and rapid eye movement (REM) sleep more than oxygen, continuous positive
      airway pressure or bi-level treatments. ASV can also more effectively reduce central apnea
      and overall apnea/hypopnea index (AHI) in patients on long-term opiates, and appears to
      effectively treat Complex Sleep Apnea Syndrome. It is more effective than other forms of
      non-invasive ventilation for patients with central and/or mixed apnea or periodic breathing,
      and is better tolerated.

      This is a prospective, randomised, crossover, observational study. Subjects will spend one
      night on conventional ASV and one night on modified ASV with full in-lab polysomnography
      (PSG) during therapy on both nights.

      Objective and subjective parameters will be recorded and analysed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea/Hypopnea Index (AHI)</measure>
    <time_frame>One night</time_frame>
    <description>Physiological sleep signals including pulse oximetry (SpO2), respiratory effort and nasal flow, will be recorded, analysed and reported in the form of an index per hour of sleep. Apnea-Hypopnea Index is calculated counting all apneas (reduction of respiratory flow by &gt;90% for at least 10 seconds) plus all hypopneas (reduction of respiratory flow by &gt;30% for at least 10 seconds with a 4% SpO2 reduction) divided by hours of sleep.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen Desaturation Index (ODI)</measure>
    <time_frame>One night</time_frame>
    <description>Oxygen desaturation index based on SpO2 measurement of number of dips (number of times per hour of sleep that SpO2 Drops by at least 3% below the basic value) will be recorded, analysed and reported.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Periodic Breathing</condition>
  <condition>Breathing-Related Sleep Disorder</condition>
  <arm_group>
    <arm_group_label>Modified ASV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Modified ASV Enhanced ASV algorithm which includes auto-adjusting expiratory pressure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional ASV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional ASV This is the current (predicate) ASV algorithm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Modified Adaptive Servoventilation Device</intervention_name>
    <description>The modified ASV has a greater adaptive response to meet a target ventilation level that is constantly being assessed.</description>
    <arm_group_label>Modified ASV</arm_group_label>
    <other_name>ResMed Enhanced ASV</other_name>
    <other_name>ASVAuto</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional Adaptive Servoventilation device</intervention_name>
    <description>Pressure support ventilation adapts to meet a target ventilation level that is constantly being assessed.</description>
    <arm_group_label>Conventional ASV</arm_group_label>
    <other_name>ResMed AutoSet CS2</other_name>
    <other_name>ResMed VPAP Adapt SV</other_name>
    <other_name>ResMed S9 VPAP Adapt</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21+ years old

          -  Chronic ResMed ASV therapy patient

          -  Current ASV therapy for at least 4 weeks

          -  Able to understand fully the study information and participation requirements

          -  Provide signed informed consent

        Exclusion Criteria:

          -  Acute cardiac decompensation

          -  Acute myocardial infarction within last 3 months

          -  Resuscitation within last 3 months

          -  Stroke with swallowing disorders or persistent hemiparesis

          -  Blood pressure test at end expiratory pressure (EEP) 10cmH2O not passed

          -  Untreated restless legs syndrome

          -  Alcohol or drug abuse

          -  Known cancer

          -  Pregnancy

          -  Conditions that could interfere with patients participating in and completing the
             protocol and/or the investigator deems their enrolment unsuitable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olaf Oldenburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart and Diabetes Centre, Ruhr University Bochum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart and Diabetes Centre, Ruhr University Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North Rhine Westphalia</state>
        <zip>D-32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Teschler H, Döhring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med. 2001 Aug 15;164(4):614-9.</citation>
    <PMID>11520725</PMID>
  </reference>
  <reference>
    <citation>Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1109-14. Epub 2003 Aug 19.</citation>
    <PMID>12928310</PMID>
  </reference>
  <reference>
    <citation>Schädlich S, Königs I, Kalbitz F, Blankenburg T, Busse HJ, Schütte W. [Cardiac efficiency in patients with Cheyne-Stokes respiration as a result of heart insufficiency during long-term nasal respiratory treatment with adaptive servo ventilation (AutoSet CS)]. Z Kardiol. 2004 Jun;93(6):454-62. German.</citation>
    <PMID>15252739</PMID>
  </reference>
  <reference>
    <citation>Oldenburg O, Schmidt A, Lamp B, Bitter T, Muntean BG, Langer C, Horstkotte D. Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail. 2008 Jun;10(6):581-6. doi: 10.1016/j.ejheart.2008.04.007. Epub 2008 May 16.</citation>
    <PMID>18486550</PMID>
  </reference>
  <reference>
    <citation>Javaheri S, Malik A, Smith J, Chung E. Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med. 2008 Aug 15;4(4):305-10.</citation>
    <PMID>18763420</PMID>
  </reference>
  <results_reference>
    <citation>Oldenburg O, Spießhöfer J, Fox H, Prib N, Horstkotte D. Performance of conventional and enhanced adaptive servoventilation (ASV) in heart failure patients with central sleep apnea who have adapted to conventional ASV. Sleep Breath. 2015 Sep;19(3):795-800. doi: 10.1007/s11325-014-1083-9. Epub 2014 Nov 21.</citation>
    <PMID>25413958</PMID>
  </results_reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2011</study_first_submitted>
  <study_first_submitted_qc>July 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2011</study_first_posted>
  <results_first_submitted>September 20, 2012</results_first_submitted>
  <results_first_submitted_qc>January 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 20, 2017</results_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Clinic population already established on ASV therapy.</recruitment_details>
      <pre_assignment_details>All enrolled participants continued through to group assignment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>First Modified ASV Then Conventional ASV</title>
          <description>Patients receive Modified ASV algorithm as therapy for 1 night, then Conventional ASV for 1 night</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All 21 patients completed the cross over study design</population>
      <group_list>
        <group group_id="B1">
          <title>Modified ASV/Conventional ASV</title>
          <description>Therapy used was Modified ASV and then Conventional ASV</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.9" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea/Hypopnea Index (AHI)</title>
        <description>Physiological sleep signals including pulse oximetry (SpO2), respiratory effort and nasal flow, will be recorded, analysed and reported in the form of an index per hour of sleep. Apnea-Hypopnea Index is calculated counting all apneas (reduction of respiratory flow by &gt;90% for at least 10 seconds) plus all hypopneas (reduction of respiratory flow by &gt;30% for at least 10 seconds with a 4% SpO2 reduction) divided by hours of sleep.</description>
        <time_frame>One night</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Modified ASV AHI</title>
            <description>1 night of modified ASV therapy with full polysomnography measurements</description>
          </group>
          <group group_id="O2">
            <title>Conventional ASV AHI</title>
            <description>1 night of conventional ASV therapy with full polysomnography measurements</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea/Hypopnea Index (AHI)</title>
          <description>Physiological sleep signals including pulse oximetry (SpO2), respiratory effort and nasal flow, will be recorded, analysed and reported in the form of an index per hour of sleep. Apnea-Hypopnea Index is calculated counting all apneas (reduction of respiratory flow by &gt;90% for at least 10 seconds) plus all hypopneas (reduction of respiratory flow by &gt;30% for at least 10 seconds with a 4% SpO2 reduction) divided by hours of sleep.</description>
          <units>Events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="4.7"/>
                    <measurement group_id="O2" value="6.4" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority</non_inferiority_desc>
            <p_value>0.022</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.5</param_value>
            <ci_percent>80</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Desaturation Index (ODI)</title>
        <description>Oxygen desaturation index based on SpO2 measurement of number of dips (number of times per hour of sleep that SpO2 Drops by at least 3% below the basic value) will be recorded, analysed and reported.</description>
        <time_frame>One night</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Modified ASV ODI</title>
            <description>1 night of modified ASV therapy with full polysomnography measurements</description>
          </group>
          <group group_id="O2">
            <title>Conventional ASV ODI</title>
            <description>1 night of conventional ASV therapy with full polysomnography measurements</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Desaturation Index (ODI)</title>
          <description>Oxygen desaturation index based on SpO2 measurement of number of dips (number of times per hour of sleep that SpO2 Drops by at least 3% below the basic value) will be recorded, analysed and reported.</description>
          <units>Events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="5.3"/>
                    <measurement group_id="O2" value="8.2" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority</non_inferiority_desc>
            <p_value>0.016</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.00</param_value>
            <ci_percent>80</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Conventional ASV</title>
          <description>Intervention was conventional ASV therapy</description>
        </group>
        <group group_id="E2">
          <title>Modified ASV</title>
          <description>Intervention was modified ASV therapy</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Diagnostic Coronary Angiogram</sub_title>
                <description>Coronary angiogram performed as patient (NYHA Class III) reported increased dyspnea.
No relation to medical device or clinical trial. Expected event because of patient illness.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>None to report</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Director Medical Affairs</name_or_title>
      <organization>ResMed</organization>
      <phone>+6128841000</phone>
      <email>adamb@resmed.com.au</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

